# Pharmacy Prior Authorization Scenario

## Trigger Phrases

- pharmacy prior auth
- rx prior auth
- drug prior auth
- medication PA
- step therapy
- step therapy override
- formulary exception
- quantity limit override
- non-formulary
- PA required
- PA rejected
- pharmacy authorization

## Parameters

| Parameter | Type | Default | Options |
|-----------|------|---------|---------|
| pa_type | string | clinical_pa | formulary_exception, step_therapy_override, quantity_limit, age_edit, clinical_pa, specialty |
| decision | string | approved | approved, denied, pending, cancelled |
| urgency | string | standard | standard, urgent, expedited |
| drug_category | string | brand | generic, brand, specialty |
| outcome | string | approved | approved, denied, partial, pended |

## Pharmacy PA Workflow

### Request Lifecycle
```
1. Claim submitted, PA required (reject code 75)
   ↓
2. Pharmacy or prescriber initiates PA request
   ↓
3. Clinical review (criteria check)
   ↓
4. Decision: Approved / Denied / Pended
   ↓
5. If approved: Override code issued, claim resubmitted
   ↓
6. If denied: Appeal or therapeutic alternative
```

### Turnaround Times

| Urgency | Standard | Expedited |
|---------|----------|-----------|
| Standard | 72 hours | 24 hours |
| Medicare Part D | 72 hours | 24 hours |
| Commercial Urgent | 24 hours | Same day |

## PA Types

### Formulary Exception
Request to cover a non-formulary drug.

**When Required:**
- Drug not on plan formulary
- Brand requested when generic available
- Non-preferred drug without trying preferred alternative

**Approval Criteria:**
1. Medical necessity documentation
2. Failed/contraindicated formulary alternatives
3. Prescriber attestation

**Example Request:** "Generate a PA for non-formulary brand medication"

### Step Therapy Override
Request to skip required first-line therapy.

**When Required:**
- Drug requires trial of step 1 therapy first
- Patient new to therapy or new to plan
- Step therapy protocol not satisfied

**Approval Criteria:**
1. Previous trial of required drug(s)
2. Therapeutic failure documented
3. Contraindication to first-line agents
4. Clinical rationale for starting at advanced step

**Example Request:** "Generate a step therapy override for a biologic"

### Quantity Limit Override
Request to exceed plan quantity limits.

**When Required:**
- Quantity exceeds plan maximum
- Days supply exceeds limit
- Dosing schedule requires more units

**Approval Criteria:**
1. Prescriber-indicated dose
2. FDA-approved dosing within range
3. Clinical necessity for higher dose

**Example Request:** "Generate a quantity limit override for oxycodone"

### Age Edit Override
Request to bypass age restrictions.

**When Required:**
- Patient outside approved age range
- Pediatric patient needs adult formulation
- Geriatric restriction on specific medications

**Approval Criteria:**
1. Off-label use with clinical support
2. Specialist recommendation
3. No age-appropriate alternative

**Example Request:** "Generate an age edit override for pediatric patient"

### Clinical/Specialty PA
Full clinical review for high-cost or specialty drugs.

**When Required:**
- Specialty medications (biologics, oncology)
- High-cost medications
- Medications with serious safety concerns
- REMS program drugs

**Approval Criteria:**
1. Diagnosis confirmation
2. Clinical criteria met (lab values, prior therapies)
3. Prescriber specialty verification
4. Site of care requirements

**Example Request:** "Generate a specialty PA for adalimumab"

## PA Request Structure

### Request Data Elements
```json
{
  "pa_id": "RX-PA-2025-0001234",
  "request_date": "2025-01-15",
  "request_time": "10:30:00",
  "urgency": "standard",

  "member": {
    "member_id": "MEM001234567",
    "cardholder_id": "ABC123456789",
    "name": {
      "given_name": "Michael",
      "family_name": "Johnson"
    },
    "birth_date": "1985-03-15",
    "phone": "555-234-5678"
  },

  "rx_plan": {
    "bin": "003858",
    "pcn": "A4",
    "group_number": "RX1234",
    "rx_plan_code": "RX-COMMERCIAL-3TIER"
  },

  "prescriber": {
    "npi": "1234567890",
    "name": "Dr. Emily Chen",
    "specialty": "Rheumatology",
    "phone": "555-345-6789",
    "fax": "555-345-6790"
  },

  "medication": {
    "ndc": "00074437909",
    "drug_name": "Humira 40mg/0.4ml Pen",
    "quantity": 2,
    "days_supply": 28,
    "directions": "Inject 40mg subcutaneously every 2 weeks"
  },

  "pa_type": "specialty",
  "diagnosis": {
    "primary": {
      "code": "M05.79",
      "description": "Rheumatoid arthritis with rheumatoid factor of multiple sites"
    },
    "secondary": [
      {
        "code": "M06.00",
        "description": "Rheumatoid arthritis without rheumatoid factor, unspecified site"
      }
    ]
  },

  "clinical_information": {
    "duration_of_condition": "3 years",
    "previous_treatments": [
      {
        "drug_name": "Methotrexate",
        "dates": "2022-01 to 2024-06",
        "outcome": "Inadequate response, disease progression"
      },
      {
        "drug_name": "Sulfasalazine",
        "dates": "2023-03 to 2024-03",
        "outcome": "GI intolerance"
      }
    ],
    "lab_values": [
      {
        "test": "Rheumatoid Factor",
        "value": "85",
        "unit": "IU/mL",
        "date": "2024-12-01"
      },
      {
        "test": "CRP",
        "value": "2.8",
        "unit": "mg/dL",
        "date": "2024-12-01"
      },
      {
        "test": "ESR",
        "value": "42",
        "unit": "mm/hr",
        "date": "2024-12-01"
      }
    ],
    "supporting_documentation": [
      "Office notes from 2024-12-15",
      "Lab results from 2024-12-01",
      "X-ray report showing joint erosions"
    ]
  }
}
```

## Clinical Criteria Examples

### TNF Inhibitor (Humira, Enbrel, etc.)
```json
{
  "criteria_name": "TNF Inhibitor - Rheumatoid Arthritis",
  "approved_diagnoses": ["M05.x", "M06.x"],
  "requirements": [
    {
      "name": "diagnosis_confirmed",
      "description": "Diagnosis of rheumatoid arthritis",
      "required": true
    },
    {
      "name": "conventional_dmard_failure",
      "description": "Trial and failure of at least one conventional DMARD (methotrexate)",
      "required": true,
      "min_duration_weeks": 12
    },
    {
      "name": "no_active_infection",
      "description": "No active serious infection",
      "required": true
    },
    {
      "name": "negative_tb_test",
      "description": "Negative TB test or latent TB treatment completed",
      "required": true
    },
    {
      "name": "specialist_prescriber",
      "description": "Prescribed by rheumatologist",
      "required": true
    }
  ],
  "approval_duration_days": 365,
  "quantity_per_30_days": 2
}
```

### Step Therapy - PCSK9 Inhibitors
```json
{
  "criteria_name": "PCSK9 Inhibitor Step Therapy",
  "drugs": ["Repatha", "Praluent"],
  "approved_diagnoses": ["E78.0x", "E78.2", "I25.x"],
  "step_therapy_requirements": [
    {
      "step": 1,
      "drugs": ["atorvastatin 80mg", "rosuvastatin 40mg"],
      "min_duration_weeks": 12,
      "description": "Maximum tolerated statin"
    },
    {
      "step": 2,
      "drugs": ["ezetimibe 10mg"],
      "min_duration_weeks": 12,
      "description": "Statin + ezetimibe combination"
    }
  ],
  "override_criteria": [
    "Statin intolerance (documented myopathy)",
    "Homozygous familial hypercholesterolemia",
    "LDL-C remains >100 despite maximally tolerated therapy"
  ]
}
```

## PA Response Structure

### Approval Response
```json
{
  "pa_id": "RX-PA-2025-0001234",
  "status": "approved",
  "decision_date": "2025-01-17",
  "decision_time": "14:30:00",
  "reviewer": {
    "name": "Pharmacy Review Team",
    "credentials": "PharmD, RPh"
  },
  "approval_details": {
    "effective_date": "2025-01-17",
    "expiration_date": "2026-01-17",
    "override_code": "PA12345678",
    "approved_quantity": 2,
    "approved_days_supply": 28,
    "approved_fills": 12,
    "pharmacy_instructions": "Apply override code PA12345678 to claim submission"
  },
  "conditions": [
    "Must be dispensed by specialty pharmacy",
    "Renewal requires continued prescriber attestation"
  ],
  "messages": [
    "Prior authorization approved for 12 months",
    "CVS Specialty: 1-800-237-2767"
  ]
}
```

### Denial Response
```json
{
  "pa_id": "RX-PA-2025-0001235",
  "status": "denied",
  "decision_date": "2025-01-17",
  "decision_time": "16:45:00",
  "reviewer": {
    "name": "Dr. James Wilson",
    "credentials": "MD, Medical Director"
  },
  "denial_details": {
    "denial_reason_code": "STEP_THERAPY_NOT_MET",
    "denial_reason": "Step therapy requirements not satisfied",
    "clinical_rationale": "No documented trial of high-intensity statin prior to PCSK9 inhibitor request",
    "required_step_drugs": ["atorvastatin 80mg", "rosuvastatin 40mg"],
    "formulary_alternatives": [
      {
        "drug_name": "Atorvastatin 80mg",
        "tier": 1,
        "copay": "$10",
        "pa_required": false
      },
      {
        "drug_name": "Rosuvastatin 40mg",
        "tier": 1,
        "copay": "$10",
        "pa_required": false
      },
      {
        "drug_name": "Ezetimibe 10mg",
        "tier": 1,
        "copay": "$10",
        "pa_required": false
      }
    ]
  },
  "appeal_rights": {
    "standard_appeal_deadline": "2025-02-16",
    "expedited_appeal_available": true,
    "external_review_available": true,
    "appeal_contact": "PA Appeals Department, 1-800-555-0100"
  },
  "messages": [
    "Trial of high-intensity statin required before PCSK9 inhibitor coverage",
    "If statin intolerant, submit documentation of adverse reaction",
    "Expedited appeal available if clinically urgent"
  ]
}
```

### Pending Response
```json
{
  "pa_id": "RX-PA-2025-0001236",
  "status": "pending",
  "status_date": "2025-01-16",
  "pending_reason": "additional_information_required",
  "required_information": [
    {
      "item": "TB test results",
      "description": "Recent TB screening (within 6 months)",
      "urgent": true
    },
    {
      "item": "Lab results",
      "description": "CRP and ESR within last 30 days",
      "urgent": false
    },
    {
      "item": "Prior therapy documentation",
      "description": "Records showing methotrexate trial dates and outcome",
      "urgent": false
    }
  ],
  "response_deadline": "2025-01-23",
  "contact": {
    "phone": "1-800-555-0100",
    "fax": "1-800-555-0101",
    "portal": "https://provider.pbm.com/pa-portal"
  },
  "messages": [
    "Additional clinical information required",
    "Please respond by 2025-01-23 to avoid case closure",
    "Fax documentation with PA ID RX-PA-2025-0001236 clearly noted"
  ]
}
```

## Example Outputs

### Example 1: Approved Step Therapy Override

**Request:** "Generate an approved step therapy override for Ozempic"

```json
{
  "pa_request": {
    "pa_id": "RX-PA-2025-0001237",
    "request_date": "2025-01-15",
    "urgency": "standard",
    "pa_type": "step_therapy_override",
    "member": {
      "member_id": "MEM001234567",
      "name": { "given_name": "Maria", "family_name": "Garcia" },
      "birth_date": "1975-08-22"
    },
    "medication": {
      "ndc": "00169413312",
      "drug_name": "Ozempic 2mg/1.5ml Pen",
      "quantity": 1,
      "days_supply": 28
    },
    "diagnosis": {
      "primary": { "code": "E11.9", "description": "Type 2 diabetes without complications" }
    },
    "clinical_information": {
      "previous_treatments": [
        {
          "drug_name": "Metformin 1000mg BID",
          "dates": "2020-01 to present",
          "outcome": "Currently on therapy"
        },
        {
          "drug_name": "Glipizide 10mg BID",
          "dates": "2022-06 to present",
          "outcome": "Added to regimen, A1C remains elevated"
        }
      ],
      "lab_values": [
        { "test": "HbA1c", "value": "9.2", "unit": "%", "date": "2025-01-10" }
      ],
      "clinical_notes": "Patient has failed dual oral therapy with A1C consistently above goal. GLP-1 RA indicated for glycemic control and cardiovascular benefit."
    }
  },
  "pa_response": {
    "pa_id": "RX-PA-2025-0001237",
    "status": "approved",
    "decision_date": "2025-01-17",
    "approval_details": {
      "effective_date": "2025-01-17",
      "expiration_date": "2026-01-17",
      "override_code": "PA98765432",
      "approved_quantity": 1,
      "approved_days_supply": 28,
      "approved_fills": 12
    },
    "messages": [
      "Step therapy override approved based on dual oral therapy failure",
      "Approval valid for 12 months with up to 12 fills"
    ]
  }
}
```

### Example 2: Denied Formulary Exception

**Request:** "Generate a denied formulary exception for brand medication"

```json
{
  "pa_request": {
    "pa_id": "RX-PA-2025-0001238",
    "request_date": "2025-01-15",
    "urgency": "standard",
    "pa_type": "formulary_exception",
    "member": {
      "member_id": "MEM001234568",
      "name": { "given_name": "John", "family_name": "Smith" },
      "birth_date": "1980-03-15"
    },
    "medication": {
      "ndc": "00071015340",
      "drug_name": "Lipitor 40mg Tablet",
      "quantity": 30,
      "days_supply": 30
    },
    "diagnosis": {
      "primary": { "code": "E78.0", "description": "Pure hypercholesterolemia" }
    },
    "clinical_information": {
      "clinical_notes": "Patient requests brand Lipitor due to preference"
    }
  },
  "pa_response": {
    "pa_id": "RX-PA-2025-0001238",
    "status": "denied",
    "decision_date": "2025-01-16",
    "denial_details": {
      "denial_reason_code": "THERAPEUTIC_EQUIVALENT_AVAILABLE",
      "denial_reason": "Generic therapeutic equivalent available",
      "clinical_rationale": "Atorvastatin (generic Lipitor) is therapeutically equivalent and available on formulary at Tier 1. Brand preference without documented medical necessity does not meet exception criteria.",
      "formulary_alternatives": [
        {
          "drug_name": "Atorvastatin 40mg",
          "tier": 1,
          "copay": "$10",
          "pa_required": false
        }
      ]
    },
    "appeal_rights": {
      "standard_appeal_deadline": "2025-02-15",
      "expedited_appeal_available": false,
      "appeal_contact": "PA Appeals Department, 1-800-555-0100"
    }
  }
}
```

### Example 3: Specialty PA with Quantity Limit

**Request:** "Generate a specialty PA for Humira with quantity limit"

```json
{
  "pa_request": {
    "pa_id": "RX-PA-2025-0001239",
    "request_date": "2025-01-15",
    "urgency": "standard",
    "pa_type": "specialty",
    "member": {
      "member_id": "MEM001234569",
      "name": { "given_name": "Jennifer", "family_name": "Williams" },
      "birth_date": "1970-05-10"
    },
    "medication": {
      "ndc": "00074437909",
      "drug_name": "Humira 40mg/0.4ml Pen",
      "quantity": 4,
      "days_supply": 28,
      "directions": "Inject 40mg subcutaneously weekly"
    },
    "diagnosis": {
      "primary": { "code": "L40.50", "description": "Arthropathic psoriasis, unspecified" }
    },
    "clinical_information": {
      "previous_treatments": [
        {
          "drug_name": "Methotrexate 25mg weekly",
          "dates": "2023-01 to 2024-09",
          "outcome": "Inadequate response"
        }
      ],
      "lab_values": [
        { "test": "TB QuantiFERON", "value": "Negative", "date": "2025-01-05" },
        { "test": "Hepatitis B Surface Antigen", "value": "Negative", "date": "2025-01-05" }
      ]
    }
  },
  "pa_response": {
    "pa_id": "RX-PA-2025-0001239",
    "status": "approved",
    "decision_date": "2025-01-18",
    "approval_details": {
      "effective_date": "2025-01-18",
      "expiration_date": "2026-01-18",
      "override_code": "PA55667788",
      "approved_quantity": 4,
      "approved_days_supply": 28,
      "approved_fills": 12,
      "quantity_limit_override": true
    },
    "specialty_requirements": {
      "specialty_pharmacy_required": true,
      "designated_pharmacy": "CVS Specialty",
      "pharmacy_phone": "1-800-237-2767",
      "patient_support_program": "Humira Complete"
    },
    "messages": [
      "Weekly dosing approved for psoriatic arthritis",
      "Must use CVS Specialty pharmacy",
      "Quantity limit override granted for 4 pens per 28 days"
    ]
  }
}
```

## Validation Rules

### Request Validation
1. NDC must be valid 11-digit format
2. Diagnosis codes must support requested medication
3. Prescriber NPI must be valid and active
4. Member must have active pharmacy coverage
5. Clinical documentation must be provided for specialty drugs

### Response Validation
1. Override codes must be unique
2. Expiration date cannot exceed 365 days for most drugs
3. Approved quantity must not exceed FDA max dosing
4. Appeal deadlines must meet regulatory requirements (72 hours Medicare Part D)

## Output Formats

| Format | Request | Use Case |
|--------|---------|----------|
| JSON | default | API testing |
| NCPDP P1/P2 | "as NCPDP PA" | PA transaction |
| PDF | "PA letter" | Provider/member notification |
| CSV | "as CSV" | PA tracking report |

## Related Skills

- [SKILL.md](SKILL.md) - RxMemberSim overview
- [formulary-management.md](formulary-management.md) - Formulary and tier structure
- [specialty-pharmacy.md](specialty-pharmacy.md) - Specialty drug handling
- [dur-alerts.md](dur-alerts.md) - DUR and clinical edits
- [../../references/code-systems.md](../../references/code-systems.md) - Code systems
- [../../references/data-models.md](../../references/data-models.md) - Data models
